References
- Trott KR, Kamprad F. Radiobiological mechanisms of anti-inflammatory radiotherapy. Radiother Oncol 1999; 51: 197–203
- Little MP. Cancer after exposure to radiation in the course of treatment for benign and malignant disease. Lancet Oncol 2001; 2: 212–20
- Devine CJ, Somers KD, Jordan GH, Schlossberg SM. Proposal: Trauma as the cause of the Peyronie's lesion. J Urol 1997; 157: 285–90
- Pryor JP, Ralph DJ. Clinical presentation of Peyronie's disease. Int J Impot Res 2002; 14: 414–7
- Leer JWH, van Houtte P, Davelaar J. Indications and treatment schedules for irradiation of benign diseases: A survey. Radiother Oncol 1998; 48: 249–57
- Incrocci L. Radiotherapeutic treatment of Peyronie's disease. Expert Rev Pharmacoeconomics Outcome Res 2004; 4: 235–42
- Mourits MP, van Kempen-Harteveld ML, García MBG, Koppeschaar HPF, Tick L, Terwee CB. Radiotherapy for Graves’ orbitopathy: Randomised placebo-controlled study. Lancet 2000; 355: 1505–9
- Incrocci L, Wijnmaalen A, Slob AK, Hop WCJ, Levendag PC. Low-dose radiotherapy in 179 patients with Peyronie's Disease: Treatment outcome and current sexual functioning. Int J Radiat Oncol Biol Phys 2000; 47: 1353–6